tm
Seeing Is Believing
tm
Seeing Is Believing
MLYS is currently covered by 2 analysts with an average price target of $30.25. This is a potential upside of $16.8 (124.91%) from yesterday's end of day stock price of $13.45.
Mineralys Therapeutics, Common Stock's activity chart (see below) currently has 4 price targets and 11 ratings on display. The stock rating distribution of MLYS is 100% BUY.
Highest price target for MLYS is $30, Lowest price target is $24, average price target is $27.
Most recent stock forecast was given by RICHARD LAW from GOLDMAN SACHS on 13-Feb-2025. First documented stock forecast 07-Mar-2023.
Currently out of the existing stock ratings of MLYS, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$24
$9.68 (67.60%)
$30
4 months 3 days ago
(13-Feb-2025)
0/6 (0%)
$13.8 (135.29%)
Buy
$30
$15.68 (109.50%)
$30
4 months 3 days ago
(13-Feb-2025)
0/5 (0%)
$19.8 (194.12%)
What is MLYS (Mineralys Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on MLYS (Mineralys Therapeutics, Common Stock) with a proven track record?
Which analyst has the current lower performing score on MLYS (Mineralys Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on MLYS (Mineralys Therapeutics, Common Stock)?
Which analyst is the currently most bullish on MLYS (Mineralys Therapeutics, Common Stock)?
Which analyst is the currently most reserved on MLYS (Mineralys Therapeutics, Common Stock)?
